Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $150.18 | 8 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $49.44 | 3 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $26.66 | 1 | $0 (2019) |
| Inspire Medical Systems, Inc. | $25.11 | 1 | $0 (2023) |
| Gilead Sciences, Inc. | $20.61 | 1 | $0 (2024) |
| Abbott Laboratories | $17.49 | 1 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $10.87 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $68.81 | 4 | AstraZeneca Pharmaceuticals LP ($30.71) |
| 2023 | $43.84 | 2 | Inspire Medical Systems, Inc. ($25.11) |
| 2019 | $26.66 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($26.66) |
| 2018 | $10.87 | 1 | Janssen Pharmaceuticals, Inc ($10.87) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/16/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.61 | General |
| 04/02/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Respiratory | ||||||
| 02/23/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Diabetes Care | ||||||
| 02/20/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Respiratory | ||||||
| 11/14/2023 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Respiratory | ||||||
| 08/03/2023 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $25.11 | General |
| Category: NEUROLOGY | ||||||
| 02/10/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.66 | General |
| Category: DIABETES | ||||||
| 05/14/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $10.87 | General |
| Category: Cardiovascular & Metabolism | ||||||
About Dr. James Eshleman, DO
Dr. James Eshleman, DO is a Family Medicine healthcare provider based in Calais, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1285630889.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Eshleman, DO has received a total of $150.18 in payments from pharmaceutical and medical device companies, with $68.81 received in 2024. These payments were reported across 8 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($150.18).
Practice Information
- Specialty Family Medicine
- Location Calais, ME
- Active Since 06/28/2005
- Last Updated 11/13/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1285630889
Products in Payments
- BREZTRI (Drug) $30.71
- JARDIANCE (Drug) $26.66
- INSPIRE (Device) $25.11
- AIRSUPRA (Drug) $18.73
- FREESTYLE LIBRE 3 (Device) $17.49
- XARELTO (Drug) $10.87
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.